GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas.
Wincewicz
Andrzej
A
Department of Pathology, Maria Sklodowska-Curie Memorial Bialystok Oncology Center, Medical University of Bialystok, Ogrodowa 12, 15-027 Bialystok, Poland. ruahpolin@yahoo.com
Baltaziak
Marek
M
Kanczuga-Koda
Luiza
L
Koda
Mariusz
M
Sulkowska
Urszula
U
Sulkowski
Stanislaw
S
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D004921:Erythropoietin / Q000378:metabolism*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D051272:Glucose Transporter Type 1 / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D015854:Up-Regulation / Q000502:physiology*; D051020:bcl-X Protein / Q000378:metabolism*
C494811:BCL2L1 protein, human; D051272:Glucose Transporter Type 1; C495677:SLC2A1 protein, human; D051020:bcl-X Protein; D004921:Erythropoietin